Details for New Drug Application (NDA): 203562
✉ Email this page to a colleague
The generic ingredient in POTASSIUM CHLORIDE is calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate profile page.
Summary for 203562
Tradename: | POTASSIUM CHLORIDE |
Applicant: | Glenmark Pharms Ltd |
Ingredient: | potassium chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 203562
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 203562
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 203562 | ANDA | Redpharm Drug, Inc. | 67296-1437 | 67296-1437-2 | 2 TABLET, EXTENDED RELEASE in 1 BOTTLE (67296-1437-2) |
POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 203562 | ANDA | BluePoint Laboratories | 68001-367 | 68001-367-00 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-367-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
Approval Date: | Jul 26, 2016 | TE: | AB1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 20MEQ | ||||
Approval Date: | Jul 26, 2016 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription